Immune-gene signature: a new tool for patient selection for checkpoint inhibitors?

Navid Sobhani, Silvia P Corona, Giandomenico Roviello, Stefan Bagby, Alberto D'Angelo, Giandomenico Iezzi, Daniele Generali

Research output: Contribution to journalComment/debatepeer-review

1 Citation (SciVal)
Original languageEnglish
Pages (from-to)1327-1330
Number of pages4
JournalFuture oncology (London, England)
Volume16
Issue number19
Early online date12 May 2020
DOIs
Publication statusPublished - 31 Jul 2020

Keywords

  • checkpoint inhibitors
  • immune markers
  • immune-gene signature
  • solid tumors

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this